Dr. Yamin Tan 谭亚敏
Chief Physician
Hematology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of benign and malignant blood disorders, including leukemia, multiple myeloma, lymphoma, MDS, and anemia. Specializes in hematopoietic stem cell transplantation and immune cell therapy.
Dr. Tan holds an MD and serves as Chief Physician and master’s supervisor. Research focuses on blood disorders and stem cell transplantation. Completed a visiting fellowship at the University of Miami Hematopoietic Stem Cell Transplantation Center in 2015. Leads national and provincial research projects, has published over 10 SCI papers, and contributed to scientific awards and a patent.
Professional roles
- Member, Hematology Branch of Zhejiang Immunological Society
Name order: in Chinese the family name comes first (Tan Yamin). Papers usually list the name as Yamin Tan or Tan Y.
Selected publications
21 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Inflammation, 2025 (senior author): SYK Activation Enhances Dendritic Cell Functions in Spontaneous Rheumatoid Arthritis. PubMed 41469829
- Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2025 (senior author): [The Application Progress of Selinexor in the Treatment of Relapsed and Refractory Multiple Myeloma--Review]. PubMed 40936157
- Front Psychiatry, 2025 (senior author): Construction and evaluation of leukemia suicide risk predictive model based on SEER database. PubMed 40060745
- Ann Hematol, 2024 (senior author): The prognostic significance of genetics in acute myeloid leukemia under venetoclax-based treatment. PubMed 39467855
- Br J Hosp Med (Lond), 2024 (senior author): Clinical Characteristics and Prognostic Factors of Nephrotic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation. PubMed 39475027
- Front Public Health, 2024 (senior author): Comparison of secular trends of leukemia in China and the United States from 1990 to 2021 and their projections for the next 15 years. PubMed 39220457
- Ann Hematol, 2024 (senior author): Therapeutic progress in relapsed/refractory multiple myeloma. PubMed 38609727
- Transpl Immunol, 2022 (senior author): Chronic graft-versus-host disease-related polymyositis and myocarditis: A case report and review of the literature. PubMed 35381344
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion